Eperisone Hydrochloride - Muscle relaxant- (FDC- List )- (Aug 2006)
Drug Name:
Eperisone Hydrochloride - Muscle relaxant- (FDC- List )- (Aug 2006)
List Of Brands:
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
It has been reported that disturbance of visual accomodation occured after the concomittant use of methocarbamol with tolperisone hydrochloride
Indication:
LIST OF DRUGS DURING 2006
Sr.No- 109
Name of the Drug- Eperisone Hcl (50mg) tablet Pharmacological Classification- For neck-shoulder arm syndrome scapula
hum oral per arthiritis and low back pain
Date of Approval- 23-08-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List)
Sprain and strain Muscle cramps Low back pain Cervical spondylosis
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1. Eperisone 50mg + 10-11-2009
Paracetamol 500mg tablet
For the improvement of Mytonic conditions caused by neck shoulder
arm syndrome, scapula humoral periarthiritis and low back pain in
adults only
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
Eperisone 50mg + 10-11-2009
Paracetamol 500mg tablets
For improvement of myotic conditions caused by neck shoulder
arm syndrome, scapulhumeral peroarthiritis and low back pain
in adult patients only
2.Eperisone Hcl 50mg tablet 23-08-2006
For neck-shoulder syndrome scapula humoral and low back pain
Adverse Reaction:
Side effects of Eperisone hydrochloride are very rare. Only a few cases have been observed and none of them were of a serious nature clinically. Observed side effects are excessive relaxation, nausea, anorexia, drowsiness, skin rashes, diarrhoea, indigestion, GI disturbances,insonia, headache, constipation, etc. Non-pigmenting fixed diose eruption is a very rare case associated with eperisone.
Contra-Indications:
Patients with a history of hypersensitivity to any ingredients of the drug. Special Precautions- Eperisone should be administerd with care in the patients with a history of hypersentivity and those with hepatic function disorder Important precaution- Weakness, lightheadedness, sleepnessness or other symptoms may occur. In the event of such symptoms, the dosage should be reduced or treatment discontinued. Patients should be cautioned against engaging in potentially hazardous activities requiring alertness, such as operating machinery or driving a car.
Dosages/ Overdosage Etc:
Indication-
Sprain and strain Muscle cramps Low back pain Cervical spondylosis
Dosage-
The usual adult dosage for oral use is 3 tablets ( 150mg of eperisone hydrochloride ) daily in three divided dose after meals. Dosage may adjusted depending on the patients age and symptoms.
Pharmacology/ Pharmacokinetics:
Pharmacology- Eperisone hydrochloride supperesses intercollicular section induced decerebrate rigidity in experimental animals which is produced by different chemicals like oxotremorine, succinylcholine for evaluting new drugs with skeletal muscle relaxant property.
Interaction with Food:
Reports not available
Pregnancy and lactation:
Pregnancy- Safety for use in pregnancy has not been established. Eperisone hydrochloride should be used in pregnant women or women suspected of being pregnant, if expected therapeutic benefits are evaluted to outweigh the possible risk of of treatment. Lactation- It is advisable to avoid the administration of eperisone hydrochloride to nursing mothers. It it must be used at such times, breast feeding- should be discontinued during treatment. Pediatric use- Safety in children has not been established Use in Elderly- Since the elderly often have a physiological hypofunctoon, it is advisable to take measures such as reduction in dosage under careful supervision.